192564-13-9

192564-13-9 structure

Name: Leteprinim Potassium Salt
Chemical Name: potassium,4-[3-(6-oxo-3H-purin-9-yl)propanoylamino]benzoate
CAS Number: 192564-13-9
Molecular Formula: C₁₅H₁₂KN₅O₄
Molecular Weight: 365.38500
Catalog: Research Areas Neurological Disease
Create Date: 2017-07-30 10:08:49
Modify Date: 2024-01-12 12:08:42
Leteprinim potassium (AIT-082) is a hypoxanthine derivative neurotrophic agent. Leteprinim potassium can induce brain-derived neurotrophic factor (BDNF) mRNA production following spinal cord lesions, and nerve growth factor (NGF) mRNA production in basal forebrain. Leteprinim potassium reduces glutamate toxicity in cultured hippocampal neurons. Leteprinim potassium increases heme-oxygenase 1 and 2 mRNA levels that play role in cellular defense against reactive oxygen species. Leteprinim potassium has neuroprotective activity[1].

Name	potassium,4-[3-(6-oxo-3H-purin-9-yl)propanoylamino]benzoate
Synonyms	AIT-082 Leteprinim Potassium Salt Neotrofin Neotrofin (TN) Neotrophin Leteprinim potassium

Description	Leteprinim potassium (AIT-082) is a hypoxanthine derivative neurotrophic agent. Leteprinim potassium can induce brain-derived neurotrophic factor (BDNF) mRNA production following spinal cord lesions, and nerve growth factor (NGF) mRNA production in basal forebrain. Leteprinim potassium reduces glutamate toxicity in cultured hippocampal neurons. Leteprinim potassium increases heme-oxygenase 1 and 2 mRNA levels that play role in cellular defense against reactive oxygen species. Leteprinim potassium has neuroprotective activity[1].
Related Catalog	Signaling Pathways >> Others >> Others Research Areas >> Neurological Disease
In Vivo	Leteprinim potassium (60 mg/kg; IP; single dosage) significantly reduced the number of apoptotic neurons in hypoxic-ischemic brain injury rat pups[1]. Animal Model: Wistar rat pups (hypoxic-ischemic brain injury induced by permanent unilateral carotid ligation)[1] Dosage: 60 mg/kg Administration: IP; single dosage Result: The number of preserved neurons was significantly high in CA1, CA3 regions of hippocampus and dentate gyrus in the left hemispheres when compared with the saline-treated group. In the right hemisphere, neuronal densities of CA1, CA2, CA3 regions of hippocampus and dentate gyrus were significantly high in neotrofin treatment group when compared with the group given saline.
References	[1]. Gencpınar P, et al. Effects of neotrofin on neonatal hypoxic ischemic brain injury. Neurosci Lett. 2011 Nov 14;505(2):205-10.